Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors.

Butler, Javed; Rich, Jonathan

Butler, Javed; Rich, Jonathan.

Afiliación

Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; Baylor Scott and White Health, Dallas, Texas, USA; University of Mississippi School of Medicine, Jackson, Mississippi, USA.
Rich J; Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

JACC Heart Fail ; 12(6S): S1-S3, 2024 Jun.

Article en En | MEDLINE | ID: mdl-38839134

ABSTRACT

ABSTRACT

In this video, Javed Butler, MD, introduces the series on the use of SGLT2 inhibitors in heart failure. He discusses the epidemiology of heart failure and the effects of SGLT2 inhibitors on heart failure outcomes. Jonathan Rich, MD, joins to summarize the effects of SGLT2 inhibitors from dedicated trials in patients with heart failure.

Asunto(s)

Diabetes Mellitus Tipo 2; Insuficiencia Cardíaca; Inhibidores del Cotransportador de Sodio-Glucosa 2; Humanos; Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico; Insuficiencia Cardíaca/epidemiología; Insuficiencia Cardíaca/tratamiento farmacológico; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/epidemiología; Cardiotónicos/uso terapéutico

Palabras clave

SGLT2 inhibitors; cardiovascular outcomes; heart failure

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google